All Stories

  1. A Chinese herbal medicine preparation (Pei Tu Qing Xin) for children with moderate-to-severe atopic eczema: a pilot randomized controlled trial
  2. Medication error trends and effects of person-related, environment-related and communication-related factors on medication errors in a paediatric hospital
  3. Care and concern with cannabinoids used therapeutically
  4. Chronic use of teething gel causing salicylate toxicity
  5. A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot study
  6. Medication prescribed by Australian paediatricians: Psychotropics predominate
  7. Posaconazole
  8. Stevens-Johnson syndrome: Old and new opportunities for prevention
  9. High-Resolution Twin-Ion Metabolite Extraction (HiTIME) Mass Spectrometry: Nontargeted Detection of Unknown Drug Metabolites by Isotope Labeling, Liquid Chromatography Mass Spectrometry, and Automated High-Performance Computing
  10. Anti-infective use in children and pregnancy: current deficiencies and future challenges
  11. Enabling Equitable Access to Essential Medicines
  12. Minimizing Nephrotoxicity Using Continuous Infusion of Deoxycholate Amphotericin B
  13. Interventions to Reduce Medication Errors in Pediatric Intensive Care
  14. The addition of tramadol to the standard of IV acetaminophen and morphine infusion for postoperative analgesia in neonates offers no clinical benefit: a randomized placebo-controlled trial
  15. Pristinamycin: old drug, new tricks?
  16. Neonatal Vancomycin Continuous Infusion
  17. Medication errors in hospitalised children
  18. Case series: Elevated lead levels following ingestion of sinkers
  19. VENLAFAXINE INGESTION IN A 4-YEAR-OLD GIRL
  20. Atlantooccipital septic arthritis complicating recurrent otitis media
  21. Adverse Drug Reactions in Children – International Surveillance and Evaluation (ADVISE)
  22. Use of paracetamol and ibuprofen in children in a tertiary care hospital: are we becoming complacent?
  23. Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study
  24. Mortality in Children and Adolescents Prescribed Antipsychotic Medication
  25. A randomized controlled trial investigation of a non-stimulant in attention deficit hyperactivity disorder (ACTION): Rationale and design
  26. Adverse events associated with the use of complementary and alternative medicine in children
  27. Novel interactions between UFH and TFPI in children
  28. research paper: Clinical use of unfractionated heparin therapy in children: time for change?
  29. Parental management of childhood complaints: over-the-counter medicine use and advice-seeking behaviours
  30. Use of over-the-counter medicines for young children in Australia
  31. Mortality Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment
  32. Antibiotic Prophylaxis and Recurrent Urinary Tract Infection in Children
  33. Acute suicidality after commencing atomoxetine
  34. Minimising medication errors in children
  35. Evidence Behind the WHO Guidelines: Hospital Care for Children: What is the Evidence of Safety of Gentamicin use in Children?
  36. The New European Regulation on Pediatric Medicines
  37. Macrogol 3350 plus electrolytes for chronic constipation in children: A single-centre, open-label study
  38. BNF for Children 2006
  39. How to use medicines in children: Principles of paediatric clinical pharmacology
  40. Prescribing safely for children
  41. Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis
  42. Authors' response. Adverse drug reactions to NSAIDs
  43. Pharmacokinetics and Pharmacodynamics
  44. Book Reviews: 2
  45. The placebo (I shall please) - is it so pleasing in children?
  46. Probable herbal medication induced fulminant hepatic failure
  47. Emergence of Adverse Reactions to Tramadol in Children and Adolescents at a Paediatric Hospital
  48. Survey of complementary and alternative medicine use at a tertiary children's hospital
  49. Improving drug use for children in the developing world
  50. Lessons Learnt in Conducting a Clinical Drug Trial in Children with Asperger Syndrome
  51. Lessons learnt in conducting a clinical drug trial in children with Asperger Syndrome
  52. Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospital
  53. Isoniazid treatment of children: can genetics help guide treatment?
  54. Levocetirizine in 1 – 2 year old children: pharmacokinetic and pharmacodynamic profile
  55. Clonidine poisoning in children: A recent experience
  56. Efficacy, safety and pharmacokinetics of levocetirizine in allergic children aged 1-2 years
  57. Clinical Trials, Ethical Issues and Patient Recruitment: an Australian Perspective
  58. FLUOXETINE INDUCED AUDITORY HALLUCINATIONS IN AN ADOLESCENT
  59. The Australian paediatric pharmacology research unit (A-PPRU): A dedicated clinical trials centre for children
  60. Prescribing of Psychotropic Medications for Children by Australian Pediatricians and Child Psychiatrists
  61. Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections
  62. CYCLOSPORIN DOSING IN CHILDREN FOLLOWING RENAL TRANSPLANTATION: POPULATION PHARMACOKINETIC MODELLING
  63. Paracetamol Efficacy and Safety in Children
  64. Effect of endothelin-1 on endothelium-derived vascular responsiveness in man
  65. Prescribing for Children